TuDiabetes Live interview with Steven, Devon and Grasshopper, creators of #NoPricks

Written by

Prometheon Pharma launched it’s #NoPricks campaign in order to help bring it’s needle-free insulin delivery patch to market. Here’s their mission statement:

At Prometheon, we foresee persons with diabetes no longer needing to inject themselves daily with insulin. We envision vaccines that will not spoil in hot climates and can be administered easily, painlessly, and inexpensively to impoverished children in developing countries. We imagine once-weekly drug patches for mental health disorders and chronic diseases that maximize adherence to prescribed therapy by greatly simplifying drug regimens. We dream of fields and streams absent of medical waste because biodegradable products and manufacturing processes are created to protect the fragile ecosystems on our planet. Above all, we believe advances in drug delivery and new drug discovery can be made accessible to everyone in the world. At Prometheon, we are devoted to our mission and promise to advance global health equity and improve human existence through the pursuit and translation of scientific discovery.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

Live Interview with Grace Murphy, 10-year-old Bionic Pancreas trial participant

Written by

Grace and her mom, Nancy, will be joining us fresh from Grace’s summer camp for kids with diabetes, where she got to try out the Bionic Pancreas for ONE WEEK!

Grace has had T1D since 2011 and uses an insulin pump and continuous glucose monitor to manage her diabetes. Ever since she was diagnosed, she has continued to be very active in soccer, dance, and she has even completed two Triathlons and she plans to do more.

The Murphys met Dr. Ed Damiano at the 2014 Children with Diabetes – Friends for Life Conference in Orlando, FL after his wonderfully informative and inspiring presentation on the Bionic Pancreas. Nancy spoke with Dr. Damiano about Grace participating in his upcoming clinical trial for T1D children ages 6-11. Grace very bravely agreed to participate. The trial was scheduled to begin just two weeks later at the Clara Barton Camp in Massachusetts. Grace successfully completed the official screening process then Mama Murphy scrambled to make all the travel arrangements and get Grace enrolled at the camp. (It was a lot of work!)

On July 20th, Nancy dropped Grace off at Camp, where there were about 100 kids at camp, of which 12 girls were in the study. (A study with the boys will be coming up soon at Camp Joslin.)

Nancy also has type 1 diabetes, for almost 45 years, and can speak to the incredible advances in T1D care from the time of her diagnosis to Grace’s test-run of the BP!

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live Interview with Dr. Osama Hamdy, Co-Author of The Diabetes Breakthrough

Written by

Osama Hamdy, MD, PhD, an assistant professor of medicine at Harvard Medical School, is the founder and medical director of the obesity clinical program at the Joslin Diabetes Center. He is the creator of the Joslin Why WAIT™ program, the world’s first clinical program designed to help patients with diabetes lose weight and reverse the progressive course of their disease. Dr. Hamdy is the co-author, with Sheri Colberg, of The Diabetes Breakthrough, a 12 week weight loss program modeled after Why WAIT.

The Diabetes Breakthrough (Harlequin, 2014) unlocks the formula for halting the progression of type 2 diabetes and erasing its damage. Dr. Hamdy offers a clinically proven, 12 week diet and fitness plan modeled after his Why WAIT™ program at Joslin Diabetes Center. Readers learn to create balanced, glucose-friendly meals using foods they love, which diabetes medications cause weight gain, how to combine strength and cardio training to drop pounds but not muscle, and strategies for breaking habits and reversing the negative thinking that stymies progress. The Diabetes Breakthrough makes it possible for everyone with diabetes to achieve the results Joslin patients have enjoyed:

A 50 to 60 percent reduction in medications
An average weight loss of 25 pounds in 12 weeks
A 50 percent success rate at keeping weight off for four years
A 21 percent drop in numbers taking insulin

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

Live Interview with Chris Angell, founder of Glucolift

Written by

Christopher Angell is an entrepreneur living in San Diego, CA. He has a BA in Philosophy from Vassar College and an MBA from INSEAD. Some of his past projects include founding cultural NGOs in New York and Johannesburg, producing records and music videos in South Africa, working as an associate producer of a performing arts series at the Guggenheim Museum, and a stint as a strategic advisor for a Russian billionaire.

He founded his latest company, GlucoLift, after being diagnosed with Type 1 diabetes in 2007. Frustrated with the lack of natural, good-tasting options for treating the low blood sugar episodes so common for people living with diabetes, he created an all-natural chewable glucose tablet that lacked the unpleasant flavor and chalky residues of existing products.
“Lows are horrible, but that doesn’t mean that we have to accept a sub-par product just because it raises our blood sugar. We deserve something made from natural ingredients, that tastes great, dissolves clean, and isn’t chalky. And that works quickly and reliably. That’s why I created GlucoLift All-Natural Glucose. Glucose tablets redesigned, by someone who actually has to use them.”

-Christopher Angell, Founder, Type-1 since 2007

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live Interview with Constance Brown-Riggs, CDE, Registered Dietician and author

Written by

Constance Brown-Riggs, MSEd, RD, CDE, CDN—an award-winning RD, certified diabetes educator, and national spokesperson for the Academy of Nutrition and Dietetics, is the author of The African American Guide to Living Well With Diabetes, which received the Favorably Reviewed designation from the American Association of Diabetes Educators; Eating Soulfully and Healthfully with Diabetes; and the forthcoming book Enjoying the Flavors of the World: A Diabetes Carbohydrate and Fat Gram Guide.

Over the course of her career, Constance has established herself as an expert in nutrition, diabetes, and the cultural issues that impact the health and health care of people of color. Her work has appeared in books for health professionals and health care consumers, and she has been a featured expert in national magazines such as Essence, Real Health, Heart & Soul, Diabetic Living, Diabetic Cooking, and Diabetes Forecast, and in newspapers across the country. She also is a regular contributor to Today’s Dietitian, also serving on the magazine’s advisory board, and to MSNBC’s theGrio.com.

Constance is past president of the New York State Dietetic Association and the Long Island Dietetic Association. Her professional honors include the 2012 Award for Excellence in Consultation and Business Practice from the Academy of Nutrition and Dietetics, the 2009 Distinguished Dietitian Award from the New York State Dietetic Association, and the 2007 Diabetes Educator of the Year from the American Dietetic Association Diabetes Care and Education Practice Group.

A national speaker for PESI HealthCare, a national provider of continuing education for health care professionals, Constance has been invited to appear as a keynote speaker, presenter, or panelist at conferences and professional meetings nationally and internationally for organizations such as the St. Vincent and the Grenadines Ministry of Health, Wellness, and the Environment; the American Association of Diabetes Educators; the Academy of Nutrition and Dietetics; the Empire State Medical Association; the American Academy of Physical Therapy; the University of South Carolina; Dothan Alabama Leisure Services; the North Carolina Dietetic Association; the St. Louis Association of Diabetes Educators; and the New York State Office of Children & Family Services.

Learn more about her work at www.eatingsoulfully.com

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live Interview: Dr. Stephen Gitelman – GleeT1D Study

Written by

GleeT1D is a nationwide effort to study the effect of Gleevec on people newly diagnosed with type 1 diabetes. This study will help medical researchers determine if a short-term course of medication can have a long-term effect on the body’s ability to preserve and make insulin-producing beta cells.

Come hear Mike Lawson interview Dr. Gitelman about this study and the value of clinical trials.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live Interview with Dr. Shai Gozani, Founder and CEO of Neurometrix

Written by

Dr. Shai Gozani founded NeuroMetrix in 1996 and currently serves as Chairman of the board of directors and as our President and Chief Executive Officer.

Prior to forming the company, Dr. Gozani completed a neurophysiology research fellowship in the laboratory of Dr. Gerald Fischbach at Harvard Medical School. Dr. Gozani has published articles in the areas of basic and clinical neurophysiology, biomedical engineering and computational chemistry.

The SENSUS Pain Management System, developed by Neurometrix, is a transcutaneous electrical nerve stimulator designed for people with diabetes and chronic pain. It is worn on one or both legs and is activated by simply pressing a button. SENSUS provides pain relief by stimulating the nerves that carry normal, non-painful sensations to the brain. Stimulation of these nerves changes the levels of certain natural chemicals in the nervous system that decrease pain.

Join us to learn more about this technology, now available to people with diabetes who experience painful neuropathy.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

Live Interview: Diabetic Eye Disease, with Dr. Sunil Patel

Written by

Sunil S. Patel, MD PhD is a board certified vitreoretinal surgeon at the West Texas Retina Consultants in Abilene. Dr. Patel attended the University of California, Los Angeles for his undergraduate education, where he studied biochemistry, and received his medical degree from the University of Texas Southwestern in Dallas. Upon completing an internship in internal medicine at the Presbyterian Hospital of Dallas, Dr. Patel completed his residency in ophthalmology at the Doheny Eye Institute-Los Angeles County Hospital at the University of Southern California. He remained at the Doheny Eye Institute for two additional years to complete a surgical and medical vitreoretinal fellowship as well as a Uveitis fellowship. Dr. Patel was a Vitreoretinal Surgeon at Texas Retina Associates until 2000, when he joined West Texas Retina Consultants as a Staff Vitreoretinal Surgeon. He also serves as an Assistant Clinical Professor in the Department of Ophthalmology at the Texas Tech University School of Medicine.

Dr. Patel received his PhD in Immunology from the University of Texas Southwestern Graduate School of Biomedical Sciences as part of the Medical Scientist Training Program. He is the President of Integrated Clinical Research, a center which conducts medical device and pharmaceutical research focused on retina and vitreous conditions.

Dr. Patel’s clinical practice focuses on the medical and surgical treatment of diseases involving vision, specifically the retina and vitreous. He is actively involved in the development of new therapeutic modalities for vitreoretinal diseases including age-related macular degeneration and diabetic macular edema. Dr. Patel is a frequent lecturer and presenter at scientific conferences and meetings and has conducted over 50 clinical research studies and authored more than 30 manuscripts.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live Interview with the creators of the Bionic Pancreas

Written by

Drs. Damiano and Russell are part of a collaborative group from Boston University and Massachusetts General Hospital working together to make automated blood glucose control a reality. Engineers from Boston University have developed a closed-loop artificial pancreas blood glucose control system that uses frequent measurements of blood glucose concentration along with subcutaneous delivery of both rapid-acting insulin and glucagon (to raise blood glucose, if necessary) as directed by a computer algorithm. The artificial endocrine pancreas automatically makes a new decision about insulin and glucagon dosing every five minutes. The system is being tested in people with type 1 diabetes at Massachusetts General Hospital, with results recently published in Science Translational Medicine.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube

TuDiabetes Live interview with Mike McCabe, Esq.: the legal side of diabetes in school

Written by

Mike McCabe, Esq. has been a true champion for Safe at School in California. In 2007 he brought the suit against the California Department of Education to allow children with diabetes to receive assistance with insulin administration from trained staff when a school nurse is not available. He won a landmark settlement which was appealed. Finally, at the end of May of this year, the California Supreme Court heard arguments on this case.

Just as he has from the start of this battle, Mike was instrumental in preparing the attorney representing the American Diabetes Association in the highest court in the state. Though the outcome will likely be unknown until August, it is very clear that Mike has shown tremendous leadership as a volunteer to ensure that children living with diabetes have their share of care and opportunities by taking this issue as far as possible in the California legal system.

Category: Nonprofits & Activism
Uploaded by: Diabetes Hands Foundation
Hosted: youtube